Factor Xa inhibitor - Bio-Technology General

Drug Profile

Factor Xa inhibitor - Bio-Technology General

Alternative Names: Factorex

Latest Information Update: 09 Oct 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator American Red Cross; Yissum Research Development Company
  • Developer Nonindustrial source; Savient Pharmaceuticals
  • Class
  • Mechanism of Action Factor Xa inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arterial occlusive disorders; Deep vein thrombosis; Thrombosis

Most Recent Events

  • 28 Dec 2000 This product is available for licensing (http://www.btgc.com)
  • 05 May 2000 Predicted peak sales have been added
  • 28 Mar 2000 A preclinical study has been added to the Thromboses pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top